http://purl.org/np/RACCJUfpvfdzAyMCB-jBgQS20Knnpt-eyfv0kro2tJLGQ#Head http://purl.org/np/RACCJUfpvfdzAyMCB-jBgQS20Knnpt-eyfv0kro2tJLGQ http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RACCJUfpvfdzAyMCB-jBgQS20Knnpt-eyfv0kro2tJLGQ#assertion http://purl.org/np/RACCJUfpvfdzAyMCB-jBgQS20Knnpt-eyfv0kro2tJLGQ http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RACCJUfpvfdzAyMCB-jBgQS20Knnpt-eyfv0kro2tJLGQ#provenance http://purl.org/np/RACCJUfpvfdzAyMCB-jBgQS20Knnpt-eyfv0kro2tJLGQ http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RACCJUfpvfdzAyMCB-jBgQS20Knnpt-eyfv0kro2tJLGQ#pubinfo http://purl.org/np/RACCJUfpvfdzAyMCB-jBgQS20Knnpt-eyfv0kro2tJLGQ http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RACCJUfpvfdzAyMCB-jBgQS20Knnpt-eyfv0kro2tJLGQ#assertion http://purl.obolibrary.org/obo/DOID_13413 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RACCJUfpvfdzAyMCB-jBgQS20Knnpt-eyfv0kro2tJLGQ#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_13413 http://purl.org/np/RACCJUfpvfdzAyMCB-jBgQS20Knnpt-eyfv0kro2tJLGQ#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RACCJUfpvfdzAyMCB-jBgQS20Knnpt-eyfv0kro2tJLGQ#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00994 http://purl.org/np/RACCJUfpvfdzAyMCB-jBgQS20Knnpt-eyfv0kro2tJLGQ#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RACCJUfpvfdzAyMCB-jBgQS20Knnpt-eyfv0kro2tJLGQ#association http://www.w3.org/2000/01/rdf-schema#label to reduce the development of drug resistant bacteria and maintain the effectiveness of neomycin sulfate tablets and other antibacterial drugs neomycin sulfate tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria when culture and susceptibility information are available they should be considered in selecting or modifying antibacterial therapy in the absence of such data local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy suppression of intestinal bacteria neomycin sulfate tablets are indicated as adjunctive therapy as part of a regimen for the suppression of the normal bacterial flora of the bowel e g preoperative preparation of the bowel it is given concomitantly with erythromycin enteric coated base see dosage and administration hepatic coma portal systemic encephalopathy neomycin sulfate has been shown to be effective adjunctive therapy in hepatic coma by reduction of the ammonia forming bacteria in the intestinal tract the subsequent reduction in blood ammonia has resulted in neurologic improvement http://purl.org/np/RACCJUfpvfdzAyMCB-jBgQS20Knnpt-eyfv0kro2tJLGQ#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RACCJUfpvfdzAyMCB-jBgQS20Knnpt-eyfv0kro2tJLGQ#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RACCJUfpvfdzAyMCB-jBgQS20Knnpt-eyfv0kro2tJLGQ#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB00994 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RACCJUfpvfdzAyMCB-jBgQS20Knnpt-eyfv0kro2tJLGQ#provenance http://purl.org/np/RACCJUfpvfdzAyMCB-jBgQS20Knnpt-eyfv0kro2tJLGQ#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RACCJUfpvfdzAyMCB-jBgQS20Knnpt-eyfv0kro2tJLGQ#pubinfo http://purl.org/np/RACCJUfpvfdzAyMCB-jBgQS20Knnpt-eyfv0kro2tJLGQ#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RACCJUfpvfdzAyMCB-jBgQS20Knnpt-eyfv0kro2tJLGQ#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RACCJUfpvfdzAyMCB-jBgQS20Knnpt-eyfv0kro2tJLGQ#sig http://purl.org/nanopub/x/hasSignature bePqS/JRbfO8I9rvywxjbt99hHJD+juUR3Njwfaf1v1q6+aWCpO7k+Q3Nu0ws0RqLvnFwDt44m3PNL2fd5oNyw+dtzoUu6thFfbroIoJ02apCwWcKwYVrOX/2X39K897L3RApoIsJNpGi5YbNmw+bu/q9Eo9DO48VpyF7VH1438= http://purl.org/np/RACCJUfpvfdzAyMCB-jBgQS20Knnpt-eyfv0kro2tJLGQ#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RACCJUfpvfdzAyMCB-jBgQS20Knnpt-eyfv0kro2tJLGQ http://purl.org/np/RACCJUfpvfdzAyMCB-jBgQS20Knnpt-eyfv0kro2tJLGQ http://purl.org/dc/terms/created 2021-06-18T09:07:06.176+02:00 http://purl.org/np/RACCJUfpvfdzAyMCB-jBgQS20Knnpt-eyfv0kro2tJLGQ http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RACCJUfpvfdzAyMCB-jBgQS20Knnpt-eyfv0kro2tJLGQ https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RACCJUfpvfdzAyMCB-jBgQS20Knnpt-eyfv0kro2tJLGQ https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RACCJUfpvfdzAyMCB-jBgQS20Knnpt-eyfv0kro2tJLGQ https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs